Real-time enrollment status for this ovarian neoplasms clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 2:56 PM UTC
| NCT Number | NCT07213804 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Neoplasms |
| Phase | PHASE3 |
| Target Enrollment | 1,630 participants |
| Active Locations | 88 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | August 21, 2026 (6 days ago) |
As of August 27, 2026: Clinical trial NCT07213804 is currently recruiting participants. This phase3 study for ovarian neoplasms is actively seeking new participants at 88 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07213804 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 88 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07213804 was last updated 6 days ago (August 21, 2026). HelloStudys verifies this status automatically.